BRAIN Biotech AG (ETR:BNN)
Germany · Delayed Price · Currency is EUR 2.890
+0.180 (6.64%)
Jun 12, 2026, 5:35 PM CET
BRAIN Biotech AG Market Cap
BRAIN Biotech AG has a market cap or net worth of €63.14 million as of June 12, 2026. Its market cap has increased by 41.67% in one year.
Market Cap
63.14M
Enterprise Value
63.69M
Revenue
48.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.89
Market Cap Chart
Since February 9, 2016, BRAIN Biotech AG's market cap has decreased from 149.34M to 63.14M, a decrease of -57.72%. That is a compound annual growth rate of -7.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 63.14M | 14.68% |
| Dec 30, 2025 | 55.06M | -29.01% |
| Dec 30, 2024 | 77.56M | -3.01% |
| Dec 29, 2023 | 79.96M | -37.33% |
| Dec 30, 2022 | 127.59M | -37.20% |
| Dec 30, 2021 | 203.18M | 13.16% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evonik Industries AG | 7.34B |
| Fuchs SE | 4.64B |
| Wacker Chemie AG | 4.57B |
| Verbio SE | 2.11B |
| AlzChem Group AG | 1.84B |
| LANXESS Aktiengesellschaft | 1.36B |
| Uzin Utz SE | 262.30M |
| H&R GmbH & Co. KGaA | 173.08M |